Citigroup’s VolitionRx Ltd VNRX Stock Holding History

Citigroup’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.76K	Buy	+436	New	+$2.08K	﹤0.01%	5439
2025 Q4	–	Sell	-17	Closed	-$236	–	6507
2025 Q3	$236	Buy	+17	New	+$226	﹤0.01%	5754
2025 Q1	–	Sell	-74	Closed	-$889	–	6000
2024 Q4	$889	Buy	+74	New	+$993	﹤0.01%	5603
2022 Q2	–	Sell	-17	Closed	-$1K	–	6695
2022 Q1	$1K	Buy	+17	New	+$964	﹤0.01%	6223
2021 Q3	–	Sell	-1	Closed	–	–	6326
2021 Q2	$0	Sell	1 -123	-99%	-$8.32K	﹤0.01%	6422
2021 Q1	$9K	Sell	124 -124	-50%	-$10.6K	﹤0.01%	5715
2020 Q4	$19K	Buy	248 +182	+276%	+$12.5K	﹤0.01%	6697
2020 Q3	$4K	Sell	66 -112	-63%	-$7.62K	﹤0.01%	7155
2020 Q2	$14K	Buy	178 +15	+9%	+$1.08K	﹤0.01%	6872
2020 Q1	$10K	Buy	+163	New	+$13.6K	﹤0.01%	7053
2017 Q4	–	Sell	-75	Closed	-$4K	–	7664
2017 Q3	$4K	Buy	+75	New	+$4.4K	﹤0.01%	6912
2015 Q2	–	Hold	0	–	–	–	7776
2015 Q1	–	Hold	0	–	–	–	7456

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Citigroup's VNRX Position: Q1 2026 in Review

Citigroup opened a new position in VolitionRx Ltd (VNRX) in Q1 2026: 436 shares worth $1.76K. The stake represents ﹤0.01% of the portfolio and ranks #5439 among its holdings. This is a return to the name: Citigroup previously reported a position in VNRX as recently as Q3 2025.

Citigroup first reported a position in VNRX in Q3 2017 and has held it in 11 quarters since. The position peaked at $19K in Q4 2020. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

Citigroup held 436 shares of VolitionRx Ltd worth $1.76K as of Q1 2026.
VolitionRx Ltd was a new Citigroup position in Q1 2026.
VolitionRx Ltd made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5439 holding.
Citigroup first reported a position in VolitionRx Ltd in Q3 2017 and has held it in 11 quarters since.
Citigroup's VolitionRx Ltd position peaked at $19K in Q4 2020.
31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.